Renato Gennaro

Dr. Renato Gennaro

orcid

Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 1995 in FEBS Letters
Verified
Journal Article
Closed access
MZMargherita Zanetti
Margherita Zanetti
RGRenato Gennaro
Renato Gennaro
DRDomenico Romeo
Domenico Romeo

30 September 2005 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
WWWei Wu
Wei Wu
SWSébastien Wieckowski
Sébastien Wieckowski
GPGiorgia Pastorin
Giorgia Pastorin
MBMonica Benincasa
Monica Benincasa
CKCédric Klumpp
Cédric Klumpp
Alberto BiancoAlberto Bianco
Alberto Bianco

1 May 1997 in Journal of Biological Chemistry
Verified
Journal Article
Open access
RGRichard L. Gallo
Richard L. Gallo
KKKatherine J. Kim
Katherine J. Kim
MBMerton Bernfield
Merton Bernfield
CKChristine A. Kozak
Christine A. Kozak
MZMargherita Zanetti
Margherita Zanetti
RGRenato Gennaro
Renato Gennaro
Cathelicidins are the precursors of potent antimicrobial peptides that have been identified in several mammalian species. Prior work has suggested that members of this gene family can participate in host defense through their antimicrobial effects and activate mesenchymal cells during wound repair. To permit further study of these proteins a reverse transcriptase-polymerase chain reaction approach was used to identify potential mouse homologs. A full-length 562-base pair cDNA clone was obtained encoding an NH2-terminal prepro domain homologous to other cathelicidins and a unique COOH-terminal peptide. This gene, named Cramp for cathelin-related antimicrobial peptide, was mapped to chromosome 9 at a region of conserved synteny to which genes for cathelicidins have been mapped in pig and man. Northern blot analysis detected a 1-kilobase transcript that was expressed in adult bone marrow and during embryogenesis as early as E12, the earliest stage of blood development. Reverse transcriptase-polymerase chain reaction also detected CRAMP expression in adult testis, spleen, stomach, and intestine but not in brain, liver, heart, or skeletal muscle. To evaluate further the expression and function of CRAMP, a peptide corresponding to the predicted COOH-terminal region was synthesized. CD spectral analysis showed that CRAMP will form an amphipathic alpha-helix similar to other antimicrobial peptides. Functional studies showed CRAMP to be a potent antibiotic against Gram-negative bacteria by inhibiting growth of a variety of bacterial strains (minimum inhibitory concentrations 0.5-8.0 microM) and by permeabilizing the inner membrane of Escherichia coli directly at 1 microM. Antiserum against CRAMP revealed abundant expression in myeloid precursors and neutrophils. Thus, CRAMP represents the first antibiotic peptide found in cells of myeloid lineage in the mouse. These data suggest that inflammatory cells in the mouse can use a nonoxidative mechanism for microbial killing and permit use of the mouse to study the role such peptides play in host defense and wound repair.

30 April 2009 in Biomacromolecules
Verified
Journal Article
Closed access
ATAndrea Travan
Andrea Travan
CPChiara Pelillo
Chiara Pelillo
Ivan DonatiIvan Donati
Ivan Donati
Eleonora MarsichEleonora Marsich
Eleonora Marsich
MBMonica Benincasa
Monica Benincasa
SPSergio Paoletti
Sergio Paoletti

1 March 2016 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
DXDaniela Xhindoli
Daniela Xhindoli
SPSabrina Pacor
Sabrina Pacor
MBMonica Benincasa
Monica Benincasa
MSMarco Scocchi
Marco Scocchi
RGRenato Gennaro
Renato Gennaro
SPSabrina Pacor
Sabrina Pacor

19 May 2011 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
MSMarco Scocchi
Marco Scocchi
SPSabrina Pacor
Sabrina Pacor
RGRenato Gennaro
Renato Gennaro